Video content above is prompted by the following: Parkinson disease management presents significant clinical challenges when distinguishing between dy...

Migraine, a leading cause of global disability, represents a complex neurobiological disorder with a range of symptoms, including headache, sensory se...

Early Genetic Testing as the Foundation The most critical step in improving uptake of newer Dravet syndrome therapies is encouraging clinicians to ove...

According to a new announcement, Eisai and Biogen have begun a rolling submission to the FDA for its subcutaneous autoinjector formulation (SC-AI) of...

A recently published study of more than 44,000 patients with idiopathic intracranial hypertension (IIH) showed that glucagon-like peptide 1 receptor a...

At Cleveland Clinic’s Neurological Institute, ethics are integrated into both clinical care and research, with an emphasis on providing patients oppor...

WATCH TIME: 5 minutes | Captions are auto-generated and may contain errors. "I think that moving forward in the clinic, it’s probably going to be poss...

A Critical Need for Early Intervention in Early Symptomatic Alzheimer’s Disease Alzheimer’s disease is a debilitating neurodegenerative disorder affec...

Recently presented data from the real-world STEER study showed that treatment with semaglutide (Wegovy; Novo Nordisk), an FDA-approved glucagon-like p...

A pooled analysis of patient data from the MICON international collaboration revealed that among patients with ischemic stroke (IS) or transient ische...